What is Ocular Therapeutix's net income?

Ocular Therapeutix (OCUL) reported net income of -$88.61M in Q1 2026.

How has Ocular Therapeutix's net income changed year-over-year?

Ocular Therapeutix's net income decreased by 38.3% year-over-year, from -$64.05M to -$88.61M.

What is the long-term trend for Ocular Therapeutix's net income?

Over 4 years (2021 to 2025), Ocular Therapeutix's net income has grown at a 152.4% compound annual growth rate (CAGR), from -$6.55M to -$265.94M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ocular Therapeutix OCUL Net Income

Net Income at other companies

Regeneron PharmaceuticalsREGN

$727.2M-10.1%

Bausch + LombBLCO

-$71M+66.5%

Tarsus Pharmaceuticals, Inc.TARS

-$6.97M+72.3%

Kodiak Sciences IncKOD

-$58.16M-1.2%

Ultragenyx PharmaceuticalRARE

-$185M-22.5%

PBH

Prestige Consumer HealthcarePBH

$53.93M+7.6%

Segments

By segment

See full

Single Reportable-$88.61M-38.3%

Other financials

Income statement

See full

Revenue$10.8M+0.8%

Gross profit$9.5M+0.2%

Operating income-$93.3M-46.0%

EPS (diluted)-$0.40-5.3%

Balance sheet

See full

Cash & equivalents$666.7M+90.7%

Total debt$79.5M+4.2%

Total equity$581.6M+119%

Total assets$732.5M+80.5%

Cash flow

See full

Operating cash flow-$66.0M-47.7%

CapEx$4.7M+141%

Free cash flow-$70.7M-51.6%

Valuation

See full

Market cap$2.21B+58.2%

Enterprise value$1.63B+40.8%

P/S42.6×+19.1×

Profitability

See full

Gross margin87.2%-3.4pp

Operating margin-575.4%+1,233pp

Net margin-558.2%+1,493pp

FCF margin-463%+2,860pp

Returns & leverage

See full

Return on equity-68.6%+17.0pp

Debt / equity0.1×-0.2×

Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ocular Therapeutix's net income?: Ocular Therapeutix (OCUL) reported net income of -$88.61M in Q1 2026.
How has Ocular Therapeutix's net income changed year-over-year?: Ocular Therapeutix's net income decreased by 38.3% year-over-year, from -$64.05M to -$88.61M.
What is the long-term trend for Ocular Therapeutix's net income?: Over 4 years (2021 to 2025), Ocular Therapeutix's net income has grown at a 152.4% compound annual growth rate (CAGR), from -$6.55M to -$265.94M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.